March 2 (Reuters) - Private equity group Clearlake
Capital is close to a deal to buy a majority stake in
Modernizing Medicine (ModMed) that could value the medical
software provider at $5.3 billion including debt, the Financial
Times reported on Sunday.
(Reporting by Gursimran Kaur in Bengaluru)